How to Titrate Off Sertraline and On to Citalopram
When switching from sertraline to citalopram, use a gradual cross-taper approach: taper sertraline slowly over 1-2 weeks while simultaneously starting citalopram at a low dose, monitoring closely for both discontinuation symptoms and serotonin syndrome, especially in the first 24-48 hours after each dose change.
Key Safety Considerations Before Starting
Assess Discontinuation Risk
Sertraline is specifically associated with discontinuation syndrome 1. Symptoms include dizziness, fatigue, lethargy, general malaise, myalgias, chills, headaches, nausea, vomiting, diarrhea, insomnia, imbalance, vertigo, sensory disturbances, paresthesias, anxiety, irritability, and agitation 1.
Screen for QT Risk with Citalopram
Citalopram carries a significant cardiac risk: it may cause QT prolongation associated with Torsade de Pointes, ventricular tachycardia, and sudden death at daily doses exceeding 40 mg/day 1. It should be avoided in patients with long QT syndrome 1. Obtain a baseline ECG if the patient has cardiac risk factors, is elderly, or will be on other QT-prolonging medications.
Recommended Cross-Taper Schedule
Week 1: Initiate the Switch
- Reduce sertraline by 50% of current dose (e.g., from 100 mg to 50 mg, or from 50 mg to 25 mg)
- Start citalopram at 10 mg daily 1
- Monitor closely for withdrawal symptoms and serotonin syndrome
Week 2: Complete Sertraline Discontinuation
- Stop sertraline completely
- Continue citalopram at 10 mg daily
- Monitor for 3-7 days before considering dose increase
Week 3 Onward: Titrate Citalopram
- If tolerated and clinically indicated, increase citalopram to 20 mg daily 1
- Further increases can occur at 1-2 week intervals 1
- Maximum dose: 40 mg/day (20 mg/day if >60 years old) 1
Critical Monitoring Points
Watch for Serotonin Syndrome (First 24-48 Hours)
When combining two serotonergic drugs, even briefly during cross-taper, monitor for 1:
- Mental status changes: confusion, agitation, anxiety
- Neuromuscular hyperactivity: tremors, clonus, hyperreflexia, muscle rigidity
- Autonomic hyperactivity: hypertension, tachycardia, arrhythmias, tachypnea, diaphoresis, shivering, vomiting, diarrhea
Advanced symptoms (fever, seizures, arrhythmias, unconsciousness) require immediate hospitalization and discontinuation of all serotonergic agents 1.
Distinguish Withdrawal from Relapse
Withdrawal symptoms typically emerge within days of dose reduction and improve within 1-2 weeks. Depression relapse develops more gradually over weeks and includes core depressive symptoms (anhedonia, hopelessness, guilt) rather than the physical/neurological symptoms of withdrawal 2.
Alternative Approach for High-Risk Patients
For patients with prior severe withdrawal symptoms, longer duration of sertraline use (>1 year), or higher doses (>100 mg/day), consider a more conservative approach 2, 3:
Extended Taper (4-6 Weeks)
- Week 1-2: Reduce sertraline by 25% (e.g., 100 mg → 75 mg)
- Week 3-4: Reduce to 50% of original dose (e.g., 75 mg → 50 mg), start citalopram 10 mg
- Week 5: Reduce sertraline to 25 mg, continue citalopram 10 mg
- Week 6: Stop sertraline, continue citalopram 10 mg
- Week 7+: Titrate citalopram as needed
This hyperbolic tapering approach (smaller absolute reductions as dose decreases) may minimize withdrawal symptoms 2, 3.
Important Drug Interaction Considerations
Citalopram/escitalopram have the least effect on CYP450 isoenzymes compared with other SSRIs and thus have a lower propensity for drug interactions 1. However, citalopram especially may interact with other drugs that prolong the QT interval 1.
Sertraline may interact with drugs metabolized by CYP2D6 1, so if the patient is on such medications, their levels may change after sertraline discontinuation.
Common Pitfalls to Avoid
Never abruptly stop sertraline without tapering—this significantly increases discontinuation syndrome risk 1, 4, 2
Do not exceed citalopram 40 mg/day (or 20 mg/day in elderly >60 years) due to cardiac risk 1
Do not rush the cross-taper—allow at least 1 week between major dose changes to assess tolerance 1
Do not ignore withdrawal symptoms—if severe symptoms emerge, slow the taper or temporarily increase the dose, then taper more gradually 2, 3
Monitor for akathisia—this can occur during withdrawal and may be mistaken for anxiety or agitation 3